RELAY THERAPEUTICS INC. - COMMON STOCK
5.6350
31-October-24 15:59:59
15 minutes delayed
Stocks
-0.0750
-1.31%
Today's range
5.6000 - 5.7550
ISIN
N/A
Source
NASDAQ
-
Relay Therapeutics to Participate in Stifel 2023 Healthcare Conference
07 Nov 2023 16:05:18 By Nasdaq GlobeNewswire
-
Relay Therapeutics Reports Third Quarter 2023 Financial Results and Corporate Highlights
02 Nov 2023 16:05:42 By Nasdaq GlobeNewswire
-
26 Oct 2023 16:05:51 By Nasdaq GlobeNewswire
-
12 Oct 2023 16:05:00 By Nasdaq GlobeNewswire
-
Relay Therapeutics Reports Second Quarter 2023 Financial Results and Corporate Highlights
08 Aug 2023 16:02:09 By Nasdaq GlobeNewswire
-
01 Aug 2023 16:05:24 By Nasdaq GlobeNewswire
-
Relay Therapeutics Announces Full Dose Escalation Data for RLY-4008
25 May 2023 17:01:31 By Nasdaq GlobeNewswire
-
Relay Therapeutics to Participate in Two Upcoming Investor Conferences
24 May 2023 16:05:03 By Nasdaq GlobeNewswire
-
Relay Therapeutics Reports First Quarter 2023 Financial Results and Corporate Highlights
04 May 2023 16:05:47 By Nasdaq GlobeNewswire
-
Relay Therapeutics to Announce First Quarter 2023 Financial Results and Corporate Highlights
27 Apr 2023 16:05:00 By Nasdaq GlobeNewswire
-
Relay Therapeutics to Participate in Two Upcoming Investor Conferences
19 Apr 2023 07:30:00 By Nasdaq GlobeNewswire
-
18 Apr 2023 10:40:00 By Nasdaq GlobeNewswire
-
Relay Therapeutics to Present Initial Clinical Data on RLY-2608 at AACR
06 Mar 2023 07:30:00 By Nasdaq GlobeNewswire
-
Relay Therapeutics to Participate in Two Upcoming Investor Conferences
01 Mar 2023 07:30:00 By Nasdaq GlobeNewswire
-
23 Feb 2023 16:05:01 By Nasdaq GlobeNewswire
-
16 Feb 2023 16:05:00 By Nasdaq GlobeNewswire
-
Relay Therapeutics to Participate in Guggenheim Healthcare Talks | Oncology Day
02 Feb 2023 07:30:00 By Nasdaq GlobeNewswire
-
Relay Therapeutics to Present at 41st Annual J.P. Morgan Healthcare Conference
03 Jan 2023 07:30:00 By Nasdaq GlobeNewswire
-
Relay Therapeutics to Participate in Two Upcoming Investor Conferences
07 Nov 2022 07:30:00 By Nasdaq GlobeNewswire